As a common action of PTEN-knockout mice, Ipra treatment improved insulin resistance via its insulin-independent glucose-lowering action; indeed, the present study has shown that Ipra treatment improves both hyperglycemia and hyperinsulinemia with increased Akt phosphorylation in abdominal PVAT compared to vehicle treatment. Here, AKT1 is linked to Hyperglycemia.